Herpes medication does not reduce risk of HIV infection in individuals with HSV-2

User rating: 4 / 5 after 1 vote(s)

An international clinical trial has found that acyclovir, a common medication for treating herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, does not reduce the risk of HIV infection when taken by people infected with HSV-2. Multiple studies have shown that people with HSV-2 have a higher risk of acquiring HIV.


Full story »

All News summaries from Medicine & Health news
All News summaries for February 06, 2008

Vitamin D protects cells from stress that can lead to cancer

4 minutes ago | User rating: not rated yet
By inducing a specific gene to increase expression of a key enzyme, vitamin D protects healthy prostate cells from the damage and injuries that can lead to cancer, University of Rochester Medical Center researchers report.

Depression and anger can plague recent university graduates: Study

6 minutes ago | User rating: not rated yet
The post-university years can start out tough. The good news: it gets better. A new University of Alberta study of almost 600 of its graduates (ages 20-29 years old) tracked mental health symptoms in participants for seven ...

Researchers find link between psychological stress and overeating

14 minutes ago | User rating: not rated yet
Researchers at the Yerkes National Primate Research Center, Emory University, have found socially subordinate female rhesus macaques over consume calorie-rich foods at a significantly higher level than do dominant females.

Expanded food and nutrition program shows $10 benefit for each $1 spent

1 hour ago | User rating: not rated yet
A program to teach low-income adults about healthy food choices is a good bargain in terms of the health and economic benefits achieved, reports a cost-effectiveness study in the May/June issue of Journal of Nutrition ...

Novel mechanisms controlling insulin release and fat deposition discovered

1 hour ago | User rating: not rated yet
Scientists at the Swedish medical university Karolinska Institutet have in two recent studies shown that a receptor called ALK7 plays important roles in the regulation of body fat deposition as well as the release of insulin ...